Jeffrey Robert Ajer - Apr 7, 2025 Form 3 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role: Director
Signature: /s/ Jennifer Tousignant, Attorney-in-fact
Stock symbol: VRDN
Transactions as of: Apr 7, 2025
Transactions value $: $0
Form type: 3
Date filed: 4/9/2025, 04:19 PM
Previous filing: Jan 17, 2025
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney